Preferred Label : Cytarabine/High-dose Methotrexate/Rituximab Regimen;
NCIt synonyms : Rituximab-HD-MTX/ARA-C; R-HD-MTX/ARA-C; Rituximab-High-dose Methotrexate-High-dose Cytarabine; Rituximab Plus HD MTX Plus HD AraC; Rituximab/HD-Methotrexate/Cytarabine; R-HD-MTX/ARA-C Regimen; Rituximab/High-dose MTX/ARA-C Regimen;
NCIt related terms : Cytarabine, Methotrexate, Rituximab; Cytarabine, Methotrexate, Rituximab-pvvr; Cytarabine, Methotrexate, Rituximab-arrx; Cytarabine, Methotrexate, Rituximab-abbs; Cytarabine, Methotrexate, Rituximab-blit; Cytarabine, Methotrexate, Rituximab-rixa; Cytarabine, Methotrexate, Rituximab-rixi; Cytarabine, Methotrexate, Rituximab-rite;
NCIt definition : A regimen consisting of cytarabine, high-dose methotrexate and rituximab that can
be used in the treatment of chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma
(SLL), acute lymphoblastic leukemia (ALL), diffuse large B-cell lymphoma (DLBCL),
Burkitt lymphoma, and mantle cell lymphoma.;
NCI Metathesaurus CUI : CL538181;
Codes from synonyms : 10876; 128539; 128696; 128225; 127754; 127911; 128382; 128068;
Origin ID : C140103;
UMLS CUI : C4682704;
Semantic type(s)
- chemotherapy_regimen_has_component
- concept_is_in_subset
